Personalis

Business Data, Corporate Office and Headquarter Address

About

Personalis is Drug Discovery in United States that focus on generation cancer immunotherapies business. Founded in 2011. They cover business area such as Personalis Inc, a provider, advanced genomic sequencing and analytic solution, personalized cancer vaccine, one segment, sale, datum analysis service, its product, NeXT Dx Test.

Business Type

Drug Discovery

Country

United States

Founded

2011
( 13 years old in 2024 )

Company Focus

Generation Cancer Immunotherapies

Website

-

Corporate Office and Headquarter Office address:

1330 O'Brien Drive
Menlo Park, CA 94025
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

Personalis Inca provideradvanced genomic sequencing and analytic solutionpersonalized cancer vaccineone segmentsaledatum analysis serviceits productNeXT Dx Test

* We use standard office opening hours in near Personalis's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Personalis Frequently Asked Questions

What or who is Personalis?

Personalis is Drug Discovery business from United States that founded in 2011 (13 years old in 2024), Personalis business is focusing on Generation Cancer Immunotherapies.

Where is Personalis headquarter and corporate office address?

Personalis headquarter office and corporate office address is located in 1330 O'Brien Drive Menlo Park, CA 94025 United States.

Where is Personalis country origins?

Personalis was founded in United States.

What is Generation Cancer Immunotherapies business focus on?

In 2024, Personalis is currently focus on generation cancer immunotherapies sector.

Generation Cancer Immunotherapies Business Interest from Google Trend

Above is snippet of Google Trends for "generation cancer immunotherapies" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Personalis, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.